市場調査レポート

商品コード

1458413

動物感染症診断市場の評価：技術・動物タイプ・感染タイプ・エンドユーザー・地域別の機会および予測 (2017-2031年)

Veterinary Infectious Disease Diagnostics Market Assessment, By Technology, By Animal Type, By Infection Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年04月01日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 231 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の動物感染症診断の市場規模は、2023年の21億1,000万米ドルから、2024年から2031年の予測期間中は9.25%のCAGRで推移し、2031年には42億8,000万米ドルの規模に成長すると予測されています。

市場拡大の背景には、コンパニオンアニマルの飼育の増加、R&D活動の活発化、食肉製品の消費の拡大、人畜共通感染症の流行増加があります。

コンパニオンアニマルの人気の高まり：

コンパニオンアニマルの飼育が増加しているのは、無条件の愛や忠誠心など、コンパニオンアニマルが示すさまざまな情緒的利点に起因しています。これらの動物はまた、世話をする人がより活動的で健康的なライフスタイルを送ることができるようになるなど、さまざまな健康上の利点も提供します。コンパニオンアニマルは、うつ病、ストレス、孤立、不安、恐怖など、精神疾患を患う人々を悩ませるさまざまな負の感情を軽減することが証明されています。また、ポジティブな感情を高めるための強力な化学物質を脳と体に与えてくれます。コンパニオンアニマルは、精神疾患を抱える人々に平常心を与え、日常生活を安定させるため、飼育が増えています。

R&D活動の増加：

斬新で先進的な診断ソリューションの開発に向けた投資と、中小企業や新興企業の台頭の増加が、市場に有利な成長機会をもたらしています。このような活動は、世界各地における動物医療インフラの急速な拡大によっても促進されています。診断の道程において、R&D活動は、コンセプトやアイデアを診断技術やツールに変換することで、さまざまな課題に取り組む研究者を支援します。

北米が大きな市場シェアを占める見込み：

高度な診断ソリューションのアベイラビリティの増加、可処分所得の高さ、ペット保険の人気の高まり、ペットやコンパニオンアニマルの飼育の増加が、北米の動物感染症診断市場の成長を支える主な要因の一部です。Forbesによると、米国におけるペットの飼育率は過去数年間で大幅に上昇しました。2024年現在、同国の世帯の約66%がペットを飼っていると推定されています。さまざな主要参入企業の強力なプレゼンスとペット医療インフラの拡大により、斬新な製品とサービスのアベイラビリティが高まっていることが、北米の市場需要をさらに押し上げています。

当レポートでは、世界の動物感染症診断の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

市場規模・予測
技術別
- 分子診断
- 免疫診断
- 尿検査
- 血液学
- その他
動物タイプ別
- 食用動物
- ペット
感染タイプ別
- ウイルス感染
- 寄生虫感染症
- 細菌感染症
- その他
エンドユーザー別
- 獣医ラボ・診療所
- ポイントオブケア/院内検査
- リファレンスラボ
- その他
地域別
- 北米
- 南米
- 欧州
- アジア太平洋
- 中東・アフリカ
企業別市場シェア

第5章世界の動物感染症診断市場の展望：地域別

北米
南米
欧州
アジア太平洋
中東・アフリカ

第6章市場マッピング

航空機タイプ別
タイプ別
エンドユーザー別
サブフレームワーク別
地域別

第7章マクロ環境と産業構造

需給分析
輸入輸出分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長抑制要因 (課題と抑制)

第9章規制の枠組みとイノベーション

特許情勢
規制当局の承認
イノベーション/新興技術

第10章主要企業の情勢

市場リーダー上位5社の競合マトリックス
市場リーダー上位5社の市場収益分析
M&A・ジョイントベンチャー (該当する場合)
SWOT分析（参入5社）
特許分析（該当する場合）

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

Biomerieux S.A.
Zoetis, Inc.
IDEXX Laboratories, Inc.
Indical Bioscience
Heska Corporation
IDVet
Thermo Fisher Scientific Inc.
Virbac
Randox Laboratories Ltd.
Neogen Corporation

第14章戦略的提言

第15章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1.Global Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 2.Global Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 3.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 4.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 5.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 6.Global Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 7.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Region, 2017-2031F
Figure 8.North America Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 9.North America Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 10.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 11.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 12.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 13.North America Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 14.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
Figure 15.United States Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 16.United States Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 17.United States Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 18.United States Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 19.United States Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 20.United States Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 21.Canada Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 22.Canada Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 23.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 24.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 25.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 26.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 27.Mexico Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 28.Mexico Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 29.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 30.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 31.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 32.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 33.Europe Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 34.Europe Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 35.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 36.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 37.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 38.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 39.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
Figure 40.Germany Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 41.Germany Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 42.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 43.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 44.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 45.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 46.France Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 47.France Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 48.France Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 49.France Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 50.France Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 51.France Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 52.Italy Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 53.Italy Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 54.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 55.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 56.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 57.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 58.United Kingdom Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 59.United Kingdom Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 60.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 61.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 62.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 63.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 64.Russia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 65.Russia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 66.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 67.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 68.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 69.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 70.Netherlands Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 71.Netherlands Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 72.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 73.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 74.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 75.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 76.Spain Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 77.Spain Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 78.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 79.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 80.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 81.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 82.Turkey Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 83.Turkey Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 84.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 85.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 86.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 87.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 88.Poland Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 89.Poland Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 90.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 91.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 92.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 93.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 94.South America Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 95.South America Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 96.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 97.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 98.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 99.South America Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 100.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
Figure 101.Brazil Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 102.Brazil Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 103.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 104.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 105.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 106.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 107.Argentina Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 108.Argentina Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 109.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 110.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 111.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 112.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 113.Asia-Pacific Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 114.Asia-Pacific Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 115.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 116.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 117.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 118.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 119.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
Figure 120.India Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 121.India Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 122.India Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 123.India Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 124.India Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 125.India Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 126.China Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 127.China Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 128.China Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 129.China Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 130.China Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 131.China Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 132.Japan Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 133.Japan Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 134.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 135.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 136.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 137.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 138.Australia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 139.Australia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 140.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 141.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 142.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 143.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 144.Vietnam Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 145.Vietnam Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 146.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 147.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 148.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 149.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 150.South Korea Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 151.South Korea Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 152.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 153.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 154.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 155.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 156.Indonesia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 157.Indonesia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 158.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 159.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 160.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 161.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 162.Philippines Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 163.Philippines Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 164.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 165.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 166.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 167.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 168.Middle East & Africa Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 169.Middle East & Africa Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 170.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 171.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 172.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 173.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 174.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
Figure 175.Saudi Arabia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 176.Saudi Arabia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 177.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 178.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 179.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 180.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 181.UAE Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 182.UAE Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 183.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 184.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 185.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 186.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 187.South Africa Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
Figure 188.South Africa Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
Figure 189.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 190.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
Figure 191.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
Figure 192.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 193.By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194.By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195.By Infection Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11210

Global veterinary infectious disease diagnostics market is projected to witness a CAGR of 9.25% during the forecast period 2024-2031, growing from USD 2.11 billion in 2023 to USD 4.28 billion in 2031. The market expansion is supported by increasing adoption of companion animals, rising research and development activities, growing consumption of meat products, and increasing prevalence of zoonotic diseases.

The increasing adoption of pets due to rising nuclear households and urbanization is propelling the requirement for veterinary infectious disease diagnostic devices and solutions. Pet owners are extremely invested in the health and well-being of their pets and ensure that they are provided with essential veterinary care. The rise in demand for veterinary infectious disease diagnostic solutions can also be attributed to the growing prevalence of various vector-borne and zoonotic diseases due to climate change, the introduction of exotic vectors, and habitat modification. To combat the spread of such diseases, the requirement for precise and rapid diagnostic tools is increasing, boosting the market expansion.

The market is also expected to witness significant growth over the forecast period owing to enhanced capabilities of diagnostic devices and the increasing availability of technologically advanced diagnostic methods, including RTPCR. Furthermore, the growing popularity of pet insurance and increasing concerns about the wellbeing of pets, coupled with rising disposable incomes, is bolstering the market growth. Growing awareness about regular health checkups for animals is also boosting the market demand. According to Forbes, approximately 5.36 million pets are insured in America, of which 20% are cats and 80% are dogs.

Growing Popularity of Companion Animals

The increased adoption of companion animals can be attributed to the various emotional benefits offered by them, including unconditional love and loyalty. These animals also offer various health benefits, including empowering their caretakers to lead more active and healthier lifestyles. Companion animals have been proven to reduce different overwhelming negative emotions that trouble those with mental illnesses, such as depression, stress, isolation, anxiety, and fear. They also provide the brain and body with powerful chemicals for boosting positive emotions. The adoption of companion animals is also increasing as they provide a sense of consistency and normalcy, stabilizing routines to individuals living with mental illness.

According to the Progressive Animal Welfare Services (PAWS), approximately one in five Canadians live with some form of mental illness as per the Mental Health Commission of Canada. It is estimated that 8.9 million Canadians (almost 23% of the country's population) will be suffering from some sort of mental illness by 2041.

Increasing Research and Development Activities

Growing investments towards the development of novel and advanced diagnostic solutions and the increasing emergence of smaller companies and startups are providing lucrative growth opportunities to the market. Such activities are also promoted by the rapid expansion of the animal healthcare infrastructure in various regions across the globe. In the diagnostic journey, research and development activities aid researchers in addressing the different challenges by translating concepts and ideas into diagnostic technologies and tools, which can then be used for identifying different infectious diseases in animals. Over the past few years, small companies and startups, including Wellness Ready, have increased their efforts toward introducing products essential for conducting point-of-care tests in veterinary medicine. Due to the different advantages associated with point-of-care tests, such as minimal sample processing, elimination of sample transportation, minimal sample requirement, and simple analytic process, their demand has been increasing for diagnosing veterinary infectious diseases.

North America Expected to Account for Significant Market Share

The increasing availability of advanced diagnostic solutions, high disposable incomes, the growing popularity of pet insurance, and rising adoption of pets and companion animals are some of the major factors supporting the North America veterinary infectious disease diagnostics market growth. According to Forbes, pet ownership in the United States significantly increased over the past few years. It is estimated that, as of 2024, approximately 66% of the households in the country own a pet. The increasing availability of novel products and services, owing to the strong presence of various key market players and the growing expansion of pet healthcare infrastructure, is further boosting the market demand in North America. Due to the growing consumption of dairy products and meat in the region and increasing awareness about the importance of maintaining the health of food-producing animals, emphasis is being put on ensuring animal health. As per the estimates of the U.S. Department of Agriculture, in 2021, 56.2 pounds of beef per person were available in the United States for human consumption and 68.1 pounds of chicken per person were available.

Immunodiagnostics to Witness Significant Expansion

The expansion of the segment can be attributed to the increased development of advanced diagnostic solutions, platforms, and novel immunoassay formats. The rising utilization of immunoassays for testing infectious diseases, the growing popularity of automation, and increasing concerns about animal fitness and health are further boosting the growth of the segment. The efforts towards enhancing the accuracy of immunoassay-based diagnostic solutions and replacement of traditional methods with tests that require less effort and time and offer improved accuracy are increasing. Strategic collaborations between leading market players are yet another major factor supporting the growth of the segment. For instance, in 2021, Indical, one of the leading providers of innovative veterinary diagnostic solutions, acquired the Svanova product portfolio from Boehringer Ingelheim, becoming the exclusive provider of their veterinary testing products, including approximately twenty-five livestock ELISA assays.

Reference Laboratories Expected to Account for a Significant Market Share

The increase in demand for veterinary infectious disease diagnostic solutions by reference laboratories can be attributed to the rise in number of veterinary practitioners in various regions across the globe and increasing rate of adoption of pets. As per the collected records from the Humane Society and ASPCA, about 3.5 to 4.1 million dogs and cats are adopted every year in the United States. Additionally, the rising investments in laboratory services owing to the growing threat of infectious diseases in animals is further supporting the segment expansion. The growing requirement for high-volume specialty and routine veterinary testing is further expected to boost the demand for reference laboratories.

Future Market Scenario (2024 - 2031F)

Due to the lack of understanding of the mechanism of various infectious diseases in animals and the availability of durable and accurate diagnostic solutions, an increase in research efforts is essential for the provision of accurate diagnostic strategies for eradicating and controlling animal diseases. An increase in investment by pharmaceutical and diagnostic companies, veterinary practices, feline-oriented nonprofits, and academic institutions is also required for creating sustainable and effective antimicrobial stewardship solutions.

In 2023, Virginia Tech Animal Laboratory Services (ViTALS) was selected as part of the Partnership to Improve Early Detection of Emerging Diseases. ViTALS, along with four other laboratories, was selected for a new partnership between the National Bio and Agro-Defense Facility (NBAF) and the National Animal Health Laboratory Network (NAHLN). The partnership is expected to address the looming threat of infectious diseases and will emphasize next-generation sequencing for evaluating and developing diagnostic solutions for zoonotic and animal diseases.

Key Players Landscape and Outlook

Key participants in the veterinary infectious disease diagnostics market are Biomerieux S.A., Zoetis, Inc., IDEXX Laboratories, Inc., Indical Bioscience, and Heska Corporation. The market is expected to witness significant growth in the coming years owing to rising research and development activities and strategic collaborations between key market players.

For instance, in 2022, INDICAL BIOSCIENCE, one of the leading providers of veterinary diagnostic solutions, entered a partnership with Evonik, one of the leading specialty chemicals companies, to expand and develop precision monitoring solutions through the ScreenFloX(R) service in poultry. The ScreenFloX(R) service combines Evonik's Precision Livestock Farming portfolio with INDICAL's veterinary diagnostic capabilities to ensure the provision of proactive analysis of the flock's pathogen status.

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Veterinary Infectious Disease Diagnostics Market Outlook, 2017-2031F

4.1.Market Size & Forecast
- 4.1.1.By Value
- 4.1.2.By Volume
4.2.By Technology
- 4.2.1.Molecular Diagnostics
- 4.2.2.Immunodiagnostics
- 4.2.3.Urinalysis
- 4.2.4.Hematology
- 4.2.5.Others
4.3.By Animal Type
- 4.3.1.Food Producing Animals
- 4.3.2.Companion Animals
4.4.By Infection Type
- 4.4.1.Viral Infections
- 4.4.2.Parasitic Infections
- 4.4.3.Bacterial Infections
- 4.4.4.Others
4.5.By End-user
- 4.5.1.Veterinary Laboratories and Clinics
- 4.5.2.Point of Care/In House Testing
- 4.5.3.Reference Laboratories
- 4.5.4.Others
4.6.By Region
- 4.6.1.North America
- 4.6.2.South America
- 4.6.3.Europe
- 4.6.4.Asia-Pacific
- 4.6.5.Middle East & Africa
4.7.By Company Market Share (%), 2023

5.Global Veterinary Infectious Disease Diagnostics Market Outlook, By Region, 2017-2031F

5.1.North America*
- 5.1.1.Market Size & Forecast
  - 5.1.1.1.By Value
  - 5.1.1.2.By Volume
- 5.1.2.By Technology
  - 5.1.2.1.Molecular Diagnostics
  - 5.1.2.2.Immunodiagnostics
  - 5.1.2.3.Urinalysis
  - 5.1.2.4.Hematology
  - 5.1.2.5.Others
- 5.1.3.By Animal Type
  - 5.1.3.1.Food Producing Animals
  - 5.1.3.2.Companion Animals
- 5.1.4.By Infection Type
  - 5.1.4.1.Viral Infections
  - 5.1.4.2.Parasitic Infections
  - 5.1.4.3.Bacterial Infections
  - 5.1.4.4.Others
- 5.1.5.By End-user
  - 5.1.5.1.Veterinary Laboratories and Clinics
  - 5.1.5.2.Point of Care/In House Testing
  - 5.1.5.3.Reference Laboratories
  - 5.1.5.4.Others
- 5.1.6.United States*
  - 5.1.6.1.Market Size & Forecast
  - 5.1.6.1.1.By Value
  - 5.1.6.1.2.By Volume
  - 5.1.6.2.By Technology
  - 5.1.6.2.1.Molecular Diagnostics
  - 5.1.6.2.2.Immunodiagnostics
  - 5.1.6.2.3.Urinalysis
  - 5.1.6.2.4.Hematology
  - 5.1.6.2.5.Others
  - 5.1.6.3.By Animal Type
  - 5.1.6.3.1.Food Producing Animals
  - 5.1.6.3.2.Companion Animals
  - 5.1.6.4.By Infection Type
  - 5.1.6.4.1.Viral Infections
  - 5.1.6.4.2.Parasitic Infections
  - 5.1.6.4.3.Bacterial Infections
  - 5.1.6.4.4.Others
  - 5.1.6.5.By End-user
  - 5.1.6.5.1.Veterinary Laboratories and Clinics
  - 5.1.6.5.2.Point of Care/In House Testing
  - 5.1.6.5.3.Reference Laboratories
  - 5.1.6.5.4.Others
- 5.1.7.Canada
- 5.1.8.Mexico

All segments will be provided for all regions and countries covered

5.2.Europe
- 5.2.1.Germany
- 5.2.2.France
- 5.2.3.Italy
- 5.2.4.United Kingdom
- 5.2.5.Russia
- 5.2.6.Netherlands
- 5.2.7.Spain
- 5.2.8.Turkey
- 5.2.9.Poland
5.3.Asia-Pacific
- 5.3.1.India
- 5.3.2.China
- 5.3.3.Japan
- 5.3.4.Australia
- 5.3.5.Vietnam
- 5.3.6.South Korea
- 5.3.7.Indonesia
- 5.3.8.Philippines
5.4.South America
- 5.4.1.Brazil
- 5.4.2.Argentina
5.5.Middle East & Africa
- 5.5.1.Saudi Arabia
- 5.5.2.UAE
- 5.5.3.South Africa

6.Market Mapping, 2023

6.1.By Technology
6.2.By Animal Type
6.3.By Infection Type
6.4.By End-user
6.5.By Region

7.Macro Environment and Industry Structure

7.1.Supply Demand Analysis
7.2.Import Export Analysis
7.3.Value Chain Analysis
7.4.PESTEL Analysis
- 7.4.1.Political Factors
- 7.4.2.Economic System
- 7.4.3.Social Implications
- 7.4.4.Technological Advancements
- 7.4.5.Environmental Impacts
- 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5.Porter's Five Forces Analysis
- 7.5.1.Supplier Power
- 7.5.2.Buyer Power
- 7.5.3.Substitution Threat
- 7.5.4.Threat from New Entrant
- 7.5.5.Competitive Rivalry

8.Market Dynamics

8.1.Growth Drivers
8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

9.1.Patent Landscape
9.2.Regulatory Approvals
9.3.Innovations/Emerging Technologies

10.Key Players Landscape

10.1.Competition Matrix of Top Five Market Leaders
10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4.SWOT Analysis (For Five Market Players)
10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

13.1.Biomerieux S.A.
- 13.1.1.Company Details
- 13.1.2.Key Management Personnel
- 13.1.3.Products & Services
- 13.1.4.Financials (As reported)
- 13.1.5.Key Market Focus & Geographical Presence
- 13.1.6.Recent Developments
13.2.Zoetis, Inc.
13.3.IDEXX Laboratories, Inc.
13.4.Indical Bioscience
13.5.Heska Corporation
13.6.IDVet
13.7.Thermo Fisher Scientific Inc.
13.8.Virbac
13.9.Randox Laboratories Ltd.
13.10.Neogen Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

動物感染症診断市場の評価：技術・動物タイプ・感染タイプ・エンドユーザー・地域別の機会および予測 (2017-2031年)

Veterinary Infectious Disease Diagnostics Market Assessment, By Technology, By Animal Type, By Infection Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の動物感染症診断市場の展望

第5章世界の動物感染症診断市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

第14章戦略的提言

第15章当社について・免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Veterinary Infectious Disease Diagnostics Market Outlook, 2017-2031F

5.Global Veterinary Infectious Disease Diagnostics Market Outlook, By Region, 2017-2031F

6.Market Mapping, 2023

7.Macro Environment and Industry Structure

8.Market Dynamics

9.Regulatory Framework and Innovation

10.Key Players Landscape

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

14.Strategic Recommendations

15.About Us & Disclaimer

動物感染症診断市場の評価：技術・動物タイプ・感染タイプ・エンドユーザー・地域別の機会および予測 (2017-2031年)

Veterinary Infectious Disease Diagnostics Market Assessment, By Technology, By Animal Type, By Infection Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の動物感染症診断市場の展望

第5章 世界の動物感染症診断市場の展望：地域別

第6章 市場マッピング

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の展望

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Veterinary Infectious Disease Diagnostics Market Outlook, 2017-2031F

5.Global Veterinary Infectious Disease Diagnostics Market Outlook, By Region, 2017-2031F

6.Market Mapping, 2023

7.Macro Environment and Industry Structure

8.Market Dynamics

9.Regulatory Framework and Innovation

10.Key Players Landscape

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

14.Strategic Recommendations

15.About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の動物感染症診断市場の展望

第5章世界の動物感染症診断市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

第14章戦略的提言

第15章当社について・免責事項